CL2004000888A1 - Uso de irinotecam para preparar un medicamento util para tratar cancer de mama localmente avanzado o metastasico. - Google Patents
Uso de irinotecam para preparar un medicamento util para tratar cancer de mama localmente avanzado o metastasico.Info
- Publication number
- CL2004000888A1 CL2004000888A1 CL200400888A CL2004000888A CL2004000888A1 CL 2004000888 A1 CL2004000888 A1 CL 2004000888A1 CL 200400888 A CL200400888 A CL 200400888A CL 2004000888 A CL2004000888 A CL 2004000888A CL 2004000888 A1 CL2004000888 A1 CL 2004000888A1
- Authority
- CL
- Chile
- Prior art keywords
- irinotecam
- metastasic
- prepare
- breast cancer
- medicinal product
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46622203P | 2003-04-28 | 2003-04-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2004000888A1 true CL2004000888A1 (es) | 2005-03-18 |
Family
ID=33418353
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL200400888A CL2004000888A1 (es) | 2003-04-28 | 2004-04-27 | Uso de irinotecam para preparar un medicamento util para tratar cancer de mama localmente avanzado o metastasico. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20040266704A1 (es) |
| EP (1) | EP1620099A1 (es) |
| JP (1) | JP2006524678A (es) |
| KR (1) | KR20050116166A (es) |
| CN (1) | CN1774249A (es) |
| AU (1) | AU2004233743A1 (es) |
| BR (1) | BRPI0409870A (es) |
| CA (1) | CA2523152A1 (es) |
| CL (1) | CL2004000888A1 (es) |
| MX (1) | MXPA05011568A (es) |
| TW (1) | TW200509925A (es) |
| WO (1) | WO2004096223A1 (es) |
| ZA (1) | ZA200508696B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107456456A (zh) * | 2016-06-03 | 2017-12-12 | 江苏恒瑞医药股份有限公司 | 伊立替康或其可药用盐在制备治疗乳腺癌的药物中的用途 |
| KR102066402B1 (ko) * | 2017-12-22 | 2020-01-15 | 대화제약 주식회사 | 이리노테칸 또는 그의 약제학적으로 허용가능한 염을 포함하는 경구투여용 약제학적 조성물 |
| KR102185475B1 (ko) * | 2019-06-20 | 2020-12-02 | 대화제약 주식회사 | 이리노테칸 자유 염기를 포함하는 경구투여용 약학 조성물 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6552055B2 (en) * | 1996-12-11 | 2003-04-22 | Dana-Farber Cancer Institute | Methods and pharmaceutical compositions for inhibiting tumor cell growth |
| EP1206234A4 (en) * | 1999-06-03 | 2005-06-01 | Jessie L S Au | METHODS AND COMPOSITIONS FOR MODULATING PROLIFERATION AND CELL DEATH |
-
2004
- 2004-04-20 CA CA002523152A patent/CA2523152A1/en not_active Abandoned
- 2004-04-20 EP EP04728381A patent/EP1620099A1/en not_active Withdrawn
- 2004-04-20 CN CNA2004800104062A patent/CN1774249A/zh active Pending
- 2004-04-20 JP JP2006506578A patent/JP2006524678A/ja not_active Withdrawn
- 2004-04-20 BR BRPI0409870-6A patent/BRPI0409870A/pt not_active IP Right Cessation
- 2004-04-20 WO PCT/IB2004/001395 patent/WO2004096223A1/en active Application Filing
- 2004-04-20 KR KR1020057020425A patent/KR20050116166A/ko not_active Application Discontinuation
- 2004-04-20 MX MXPA05011568A patent/MXPA05011568A/es unknown
- 2004-04-20 AU AU2004233743A patent/AU2004233743A1/en not_active Abandoned
- 2004-04-26 US US10/832,794 patent/US20040266704A1/en not_active Abandoned
- 2004-04-26 TW TW093111614A patent/TW200509925A/zh unknown
- 2004-04-27 CL CL200400888A patent/CL2004000888A1/es unknown
-
2005
- 2005-10-26 ZA ZA200508696A patent/ZA200508696B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0409870A (pt) | 2006-05-16 |
| CA2523152A1 (en) | 2004-11-11 |
| MXPA05011568A (es) | 2005-12-14 |
| US20040266704A1 (en) | 2004-12-30 |
| EP1620099A1 (en) | 2006-02-01 |
| CN1774249A (zh) | 2006-05-17 |
| AU2004233743A1 (en) | 2004-11-11 |
| WO2004096223A1 (en) | 2004-11-11 |
| ZA200508696B (en) | 2006-07-26 |
| JP2006524678A (ja) | 2006-11-02 |
| KR20050116166A (ko) | 2005-12-09 |
| TW200509925A (en) | 2005-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2016031I2 (el) | Τοπικη φαρμακοτεχνικη μορφη ιβερμεκτινης για την θεραπεια δερματολογικων καταστασεων | |
| CL2004000797A1 (es) | Compuestos derivados de quinazolina, inhibidores de aurora quinasa; procedimiento de preparacion; composicion farmaceutica; y su uso para preparar un medicamento para tratar cancer colorrectal, de mama, de pulmon, de prostata, de vejiga, renal o panc | |
| HK1209620A1 (en) | A pharmaceutical composition comprising an omega carboxyaryl substituted diphenyl urea for the treatment of cancer | |
| BR0313373B1 (pt) | processo para fabricação contìnua de artigos descartáveis de vestir. | |
| HRP20130453T1 (en) | Dosage form that is secured against misuse | |
| EA201300242A1 (ru) | Фармацевтические композиции, содержащие замещенные ациланилиды | |
| PT1196172E (pt) | (s,s)-reboxetina para tratar a dor cronica | |
| CR8226A (es) | Proceso para la preparacion de 4-amino-3-quinolincarbonitrilos | |
| CL2008001813A1 (es) | Compuestos derivados de quinolin-3-carbonitrilo sustituidos con piperazina; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como artritis, inflamacion, cancer entre otras (div. sol. 266-04). | |
| IL178217A0 (en) | Novel synthetic c-glycolipids, their synthesis and use to treat infections, cancer and autoimmune diseases | |
| PT1294682E (pt) | Derivados de acilfenilureia processo para a sua preparacao e sua aplicacao como medicamentos | |
| IL187220A (en) | Use of sodium arsenite sodium in the preparation of a drug for the treatment of metastatic tumor diseases | |
| BR0112898B1 (pt) | processo para a preparaÇço de um material de poliuretana. | |
| IL183395A0 (en) | Meta-substituted thiazolidinones, the production thereof and their use as medicaments | |
| CL2011001122A1 (es) | Compuestos derivados de carbamatos de alquilheterociclos; procedimiento de preparacion; composicion farmaceutica; y su uso para prevenir o tratar dolores agudos o cronicos, patologias neurologicas y psiquiatricas, enfermedades cardiovasculares, entre otras. | |
| CL2004000102A1 (es) | Compuestos derivados de amidas sustituidas por carbociclos, composicion farmaceutica, utiles para tratar obesidad, hipercolesterolemia, depresion, enfermedades de la piel, cancer de tiroides y otras. | |
| IL189377A0 (en) | Combinations comprising dmxaa for the treatment of cancer | |
| CL2008000675A1 (es) | Compuestos derivados de heterociclos sulfonilados; metodo para preparar dichos compuestos; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer de mama, entre otras enfermedades. | |
| CL2004000888A1 (es) | Uso de irinotecam para preparar un medicamento util para tratar cancer de mama localmente avanzado o metastasico. | |
| IL189376A0 (en) | Combinations comprising dmxaa for the treatment of cancer | |
| GB2443588B (en) | A pharmaceutical composition useful for the treatment of prostate cancer | |
| IL175689A0 (en) | Enoxaparin for the treatment of cancer | |
| ZA200705782B (en) | Meta-substituted thiazolidinones, the production thereof and their use as medicaments | |
| ES1053064Y (es) | Dispositivo para la preparacion de un producto tal como hormigon o mortero. | |
| CL2004001607A1 (es) | Uso de gabaxafol para preparar un medicamento util en el tratamiento de la depresion. |